1.06 USD
↗ 0.04 (3.43%)LIVE (AS OF 11:05 AM EDT)
BioXcel Therapeutics, Inc. Common Stock
BTAINASDAQ • USD
Market: OPEN
Open?$1.01
High?$1.07
Low?$1.02
Prev. Close?$1.02
Volume?394.3K
Avg. Volume?2.6M
VWAP?$1.05
Rel. Volume?0.15x
Bid / Ask
Bid?$1.05 × 600
Ask?$1.06 × 300
Spread?$0.01
Midpoint?$1.06
Valuation & Ratios
Market Cap?27.6M
Shares Out?27.1M
Float?21.1M
Float %?96.3%
P/E Ratio?N/A
P/B Ratio?-0.29
EPS?-$2.58
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.82Weak
Quick Ratio?0.81Weak
Cash Ratio?0.53Adequate
Debt/Equity?-1.15Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?-0.29CHEAP▾
P/S?43.02HIGH▾
P/FCF?N/A▾
EV/EBITDA?-2.2CHEAP▾
EV/Sales?169.46HIGH▾
Returns & Efficiency
ROE?73.2%STRONG▾
ROA?-155.6%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$108.8M
Related Companies
Loading...
News
Profile
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
Employees
29
Market Cap
28.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2018-03-08
Address
555 LONG WHARF DRIVE
NEW HAVEN, CT 06511
Phone: 203-643-8060
NEW HAVEN, CT 06511
Phone: 203-643-8060